FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Final Guide on 510(k) Template for eSubmission

Federal Register notice: FDA makes available a final guidance entitled Electronic Submission Template for Medical Device 510(k) Submissions.

latest-news-card-1
Human Drugs

Expand RTOR to Cell, Tissue Products: PhRMA

PhRMA says the FDA Oncology Center of Excellence Real-Time Oncology Review (RTOR) program should be expanded to include tissue and cell products regul...

latest-news-card-1
Human Drugs

Comments on Therapeutic Equivalence Draft Guidance

Five stakeholders comment on an FDA draft guidance on therapeutic equivalence evaluations.

latest-news-card-1
Marketing

OPDP to Study TV Ad Endorsers

The CDER Office of Prescription Drug Promotion says it wants to expand a current study on endorsers in print and Internet ads to cover TV spots.

Marketing

2 Prescription Drug Promotion Studies Proposed

The CDER Office of Prescription Drug Promotion proposes to study consumer and healthcare provider perceptions about drugs that come with medication tr...

Medical Devices

FDA Approves Medtronic Indication for Onyx Stents

FDA approves two Medtronic drug-eluting stents for use in treating non-left main bifurcation lesions in the heart.

latest-news-card-1
Medical Devices

FDA Clears AI Colon Polyp Detector

FDA clears an Iterative Scopes 510(k) for SKOUT, a computer-aided polyp detection device for adults undergoing colorectal cancer screening.

latest-news-card-1
Human Drugs

User Fee Reauthorization Agreement Reached in Senate

Senate Health, Education, Labor and Pensions Committee leaders reach agreement to reauthorize FDAs user fee programs for an additional five years, wit...

latest-news-card-1
Human Drugs

Lillys Retevmo Gains Regular FDA Approval

FDA grants regular approval to Eli Lilly for its previously accelerated-approval Retevmo (selpercatinib) for treating certain adult patients with loca...

latest-news-card-1
Human Drugs

Accelerated Approval On- and Off-Ramp Approaches

Staff in the FDA Oncology Center of Excellence say ways must be found to improve studies leading to accelerated approval to shorten the time in which ...